252 results on '"GAMBERINI, MARIA RITA"'
Search Results
2. The impact of HCV chronic positivity and clearance on extrahepatic morbidity in thalassemia major patients: an observational study from MIOT Network
3. Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience
4. Increased Expression of α-Hemoglobin Stabilizing Protein (AHSP) mRNA in Erythroid Precursor Cells Isolated from β-Thalassemia Patients Treated with Sirolimus (Rapamycin)
5. Decrease in α-Globin and Increase in the Autophagy-Activating Kinase ULK1 mRNA in Erythroid Precursors from β-Thalassemia Patients Treated with Sirolimus
6. Impact of the COVID-19 Pandemic on Iron Overload Assessment by MRI in Patients with Hemoglobinopathies: The E-MIOT Network Experience
7. Decrease of α-Globin and Increase of the Autophagy-Activating Kinase ULK1 mRNA in Erythroid Precursors from β-Thalassemia Patients Treated with Sirolimus
8. The Long Scientific Journey of Sirolimus (Rapamycin): From the Soil of Easter Island (Rapa Nui) to Applied Research and Clinical Trials on β-Thalassemia and Other Hemoglobinopathies
9. Dual-energy X-ray absorptiometry pitfalls in Thalassemia Major
10. Effects of Sirolimus Treatment on Fetal Hemoglobin Production and Response to SARS-CoV-2 Vaccination: A Case Report Study
11. Left ventricle remodeling in patients with β-thalassemia major. An emerging differential diagnosis with left ventricle noncompaction disease
12. The effect of desferrioxamine chelation versus no therapy in patients with non transfusion-dependent thalassaemia: a multicenter prospective comparison from the MIOT network
13. Inflammatory and senescence‐associated mediators affect the persistence of humoral response to COVID ‐19 mRNA vaccination in transfusion‐dependent beta‐thalassemic patients
14. Reply to “Hepatocellular carcinoma in thalassemia and other hemoglobinopathies”
15. Multi-Parametric Cardiac Magnetic Resonance for Prediction of Heart Failure Death in Thalassemia Major
16. Incidence of cancer and related deaths in hemoglobinopathies: A follow‐up of 4631 patients between 1970 and 2021
17. The role of opportunistic quantitative computed tomography in the evaluation of bone disease and risk of fracture in thalassemia major
18. Left ventricular global function index is associated with myocardial iron overload and heart failure in thalassemia major patients
19. Relationship between pancreatic iron overload, glucose metabolism and cardiac complications in sickle cell disease: An Italian multicentre study
20. Beta‐thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria
21. Deep Learning Staging of Liver Iron Content From Multiecho MR Images
22. Crushed Deferasirox Film‐Coated Tablets in Pediatric Patients With Transfusional Hemosiderosis: Results From a Single‐Arm, Interventional Phase 4 Study (MIMAS)
23. Thalassemia major: prevalence and risk factors for hypercalciuria
24. Overall and complication‐free survival in a large cohort of patients with β‐thalassemia major followed over 50 years.
25. Deep Learning Staging of Liver Iron Content From Multiecho MR Images.
26. Thalassaemia is paradoxically associated with a reduced risk of in‐hospital complications and mortality in COVID‐19: Data from an international registry
27. Link between Genotype and Multi-Organ Iron and Complications in Children with Transfusion-Dependent Thalassemia
28. sj-pdf-1-tah-10.1177_20406207221100648 – Supplemental material for Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin)
29. Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-Thalassemia: additional dose role
30. sj-docx-1-tah-10.1177_20406207221134404 – Supplemental material for Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia
31. Atrial Fibrillation in β-Thalassemia: Overview of Mechanism, Significance and Clinical Management
32. Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin)
33. Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia
34. Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin)
35. National networking in rare diseases and reduction of cardiac burden in thalassemia major
36. Italian patients with hemoglobinopathies exhibit a 5‐fold increase in age‐standardized lethality due to SARS‐CoV‐2 infection
37. Incidence of cancer and related deaths in hemoglobinopathies: A follow‐up of 4631 patients between 1970 and 2021.
38. Extramedullary hematopoiesis is associated with lower cardiac iron loading in chronically transfused thalassemia patients
39. Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel
40. Impact of the preparation method of red cell concentrates on transfusion indices in thalassemia patients: A randomized crossover clinical trial
41. Hepatocellular carcinoma in thalassaemia: an update of the Italian Registry
42. National networking in rare diseases and reduction of cardiac burden in thalassemia major.
43. Italian patients with hemoglobinopathies exhibit a 5‐fold increase in age‐standardized lethality due to SARS‐CoV‐2 infection.
44. Complications of thalassemia major and their treatment
45. The Close Link of Pancreatic Iron With Glucose Metabolism and With Cardiac Complications in Thalassemia Major: A Large, Multicenter Observational Study
46. Prospective CMR Survey in Children With Thalassemia Major
47. Biventricular Reference Values by Body Surface Area, Age, and Gender in a Large Cohort of Well‐Treated Thalassemia Major Patients Without Heart Damage Using a Multiparametric CMR Approach
48. Prediction of Cardiac Complications in SCD
49. Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with β-thalassemia
50. The haemochromatosis mutations do not modify the clinical picture of thalassaemia major in patients regularly transfused and chelated
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.